Featured post
XSTAT® P30 Released
RevMedx is pleased to announce the launch of the FDA cleared XSTAT® P30 – an improved version of our revolutionary hemostatic devices. XSTAT P30 was developed in collaboration with the...
RevMedx wins MEDY award at FutureMed 2013
RevMedx’s XSTAT™ dressing was recognized with a MEDY award for the most disruptive technology at FutureMed November 2013 (Hotel Del Coronado, San Diego, California.) FutureMed is a specialized executive program...
Panakeia, LLC adds RevMedx, Inc. AirWrap™ to its Critical Care and Advanced Life Support Line of Products
Fayetteville, North Carolina and Stafford, Virginia (August 30, 2013) – Panakeia, LLC, which distributes healthcare solutions to the Military Health System, announced today it has entered into a distribution agreement...
Oregon Health and Science University and RevMedx Inc. awarded seed grant by “Saving Lives at Birth” Grand Challenge
Oregon Health and Science University (OHSU) and RevMedx Inc. won a USAID/Gates-sponsored seed grant to develop a novel treatment for postpartum hemorrhage based on RevMedx’s XSTAT™ technology. The OHSU/RevMedx proposal...
